Perspective Therapeutics, Inc. (CATX) vs Quanterix Corporation (QTRX)

Perspective Therapeutics, Inc. and Quanterix Corporation are both Medical Devices companies. Quanterix Corporation is the larger, with a market value of $130.5M against $90.0M — 1.5× the size. Quanterix Corporation grew revenue faster over the last twelve months: 22.0% against −66.9%. Quanterix Corporation has the higher net margin (−80.3% vs −28,468.0%) and the higher return on invested capital (−66.5% vs −88.4%). Across the 18 metrics below, Quanterix Corporation leads on 11 and Perspective Therapeutics, Inc. on 7.

Valuation

Metric CATX QTRX Medical Devices median
P/E n/m n/m 25.58
P/S 235.99 0.85 2.54
P/B 0.30 0.55 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA 1.13 n/m 11.51
EV/Sales (339.40) 0.25 2.72
Earnings yield (165.86%) (95.64%) (12.82%)
Free cash flow yield (125.56%) (62.97%) (8.18%)

Profitability

Metric CATX QTRX Medical Devices median
Gross margin 100.00% 44.56% 57.76%
Operating margin (30,619.07%) (99.65%) (15.07%)
Net margin (28,467.97%) (80.25%) (14.45%)
Free cash flow margin (29,630.07%) (53.24%) (3.88%)
Return on equity (39.50%) (46.48%) (10.35%)
Return on assets (33.14%) (35.41%) (17.26%)
Return on invested capital (88.41%) (66.50%) (5.27%)

Growth

Metric CATX QTRX Medical Devices median
Revenue growth (TTM) (66.88%) 21.96% 10.41%
EPS growth (last fiscal year) (13.82%) (151.00%) 28.17%
Revenue growth, 5-year CAGR (38.04%) 9.97% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CATX QTRX Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 6.61 3.40 2.74
Net debt to EBITDA 1.27 1.16 0.54

Dividend

Metric CATX QTRX Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric CATX QTRX Medical Devices median
Market cap 89.99m 130.53m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack